Amlexanox oral patch

Abstract

The invention discloses an amlexanox oral patch, which comprises a carrier layer and an adhesion layer, wherein the adhesion layer comprises material medicament amlexanox and a composite adhesive; andthe composite adhesive contains 10 to 30 weight percent of carbomer. In the invention, the composite adhesive is used, so the amlexanox oral patch has good release. Thus, a good illustration for thatthe amlexanox oral patch is of great scientific significance is provided.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to an amlexanox oral patch. Background technique [0002] Oral ulcer is a kind of common disease, and sickness rate ranks the 3rd of oral cavity disease. It generally refers to recurrent aphthous ulcers (RAUs for short), traumatic ulcers and traumatic mucosal blood blisters, which is a kind of localized ulcer damage of oral mucosa. Clinically, according to the size, quantity and duration of ulcers, they are generally divided into three types: mild, severe and herpes-like. Among them, recurrent aphthous ulcers are the most common, manifested as single or multiple superficial painful ulcers, and mostly occur in the oral mucosa without stratum corneum on the inside of the lips, the edge of the tongue, the floor of the mouth, and the cheeks. At the beginning of the disease, it was a small red spot the size of a needle tip, with burning pain. After 1 to 3 days, 1 to 2 round or oval ul...

AI Technical Summary

Problems solved by technology

As effective oromucosal administration dosage forms, although ointments, pastes, etc. can take effect quickly, most of the drugs do not play a role due to people's unconscious swallowing action and short residence time, and these dosage forms are inconvenient to use , there are also defects in the appearance, and the patient's compliance with this drug is poor, and these aspects need to be improved

Images